Dopamine transporter binding in Gilles de la Tourette syndrome: a [123I]FP‐CIT/SPECT study

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Acta Psychiatrica Scandinavica

• Publication date

  2004-02-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1111/j.0001-690X.2004.00214.xPMID 14725596
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Age-Related Decline in Striatal Dopamine TransporterBindingwith Iodine-123-$-CITSPECT

  2006cited by this paper
• Neuroleptics and Dopamine Transporters

  2004cited by this paper
• Unaltered dopamine transporter availability in adult attention deficit hyperactivity disorder.

  2002influential reference
• Age-related decline in dopamine transporters: analysis of striatal subregions, nonlinear effects, and hemispheric asymmetries.

  2002cited by this paper
• No change in striatal dopamine re-uptake site density in psychotropic drug naive and in currently treated Tourette's disorder patients: a [(123)I]-beta-CIT SPECt-study.

  2001cited by this paper
• No change in striatal dopamine re-uptake site density in psychotropic drug naive and in currently treated Tourette’s disorder patients: a [123I]-β-CIT SPECT-study

  2001cited by this paper
• Dopamine transporter binding in Gilles de la Tourette syndrome

  2000cited by this paper
• Dopamine D2 receptor imaging inGilles de la Tourette syndrome

  2000cited by this paper
• Striatal presynaptic monoaminergic vesicles are not increased in Tourette’s syndrome

  1999cited by this paper
• Effects of antipsychotic drugs on dopamine and serotonin contents and metabolites, dopamine and serotonin transporters, and serotonin1A receptors

  1999cited by this paper
• High presynaptic dopaminergic activity in children with Tourette's disorder.

  1999cited by this paper
• Course of Tic Severity in Tourette Syndrome: The First Two Decades

  1998cited by this paper
• Tourette's syndrome

  1998cited by this paper
• The metabolic anatomy of Tourette's syndrome

  1997cited by this paper
• D2-like dopamine receptor density in Tourette syndrome measured by PET.

  1997cited by this paper
• Tourette Syndrome: Prediction of Phenotypic Variation in Monozygotic Twins by Caudate Nucleus D2 Receptor Binding

  1996cited by this paper
• Comparison of iodine-123 labelled 2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and 2 beta-carbomethoxy-3 beta-(4-iodophenyl)-N-(3-fluoropropyl)nortropane for imaging of the dopamine transporter in the living human brain.

  1995cited by this paper
• [123I]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder.

  1995cited by this paper
• Cerebral morphometric abnormalities in Tourette's syndrome

  1995cited by this paper
• Comparison of iodine-123 labelled 2β-carbomethoxy-3β-(4-iodophenyl)tropane and 2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl)nortropane for imaging of the dopamine transporter in the living human brain

  1995cited by this paper
• Age-related decline in striatal dopamine transporter binding with iodine-123-beta-CITSPECT.

  1995cited by this paper
• Brain Perfusion Abnormalities in Gilles de la Tourette's Syndrome

  1995cited by this paper
• Annotation: Gilles de la Tourette syndrome--an update.

  1994influential reference
• N-omega-fluoroalkyl analogs of (1R)-2 beta-carbomethoxy-3 beta-(4-iodophenyl)-tropane (beta-CIT): radiotracers for positron emission tomography and single photon emission computed tomography imaging of dopamine transporters.

  1994cited by this paper
• PET studies of the presynaptic and postsynaptic dopaminergic system in Tourette's syndrome.

  1994cited by this paper
• Dopamine receptor availability in Tourette's syndrome.

  1994cited by this paper
• The Functional Neuroanatomy of Tourette's Syndrome: An FDG-PET Study. I. Regional Changes in Cerebral Glucose Metabolism Differentiating Patients and Controls

  1993cited by this paper
• Reduced basal ganglia volumes in Tourette's syndrome using three‐dimensional reconstruction techniques from magnetic resonance images

  1993cited by this paper
• Cocaine‐related movement disorders

  1993cited by this paper
• Volumetric MRI changes in basal ganglia of children with Tourette's syndrome

  1993cited by this paper
• SPECT imaging of cerebral blood flow in Tourette syndrome.

  1992cited by this paper
• PET studies on the integrity of the pre and postsynaptic dopaminergic system in Tourette syndrome.

  1992cited by this paper
• Elevated frontal cerebral blood flow in Gilles de la Tourette syndrome: a 99Tcm-HMPAO SPECT study.

  1992cited by this paper
• SPET Instrumentation: Characteristics and New Developments

  1991cited by this paper
• Abnormal dopamine uptake sites in postmortem striatum from patients with tourette's syndrome

  1991influential reference
• Dopamine uptake sites and dopamine receptors in Parkinson's disease and schizophrenia.

  1990cited by this paper
• Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome.

  1989cited by this paper
• The Gilles de la Tourette Syndrome: the Current Status

  1989cited by this paper
• The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity.

  1989cited by this paper
• The Psychopathology of the Gilles de la Tourette Syndrome

  1988cited by this paper
• The Hospital Anxiety and Depression Scale.

  1987cited by this paper
• The Hospital Anxiety and Depression Scale

  1983cited by this paper
• Neuropathological studies of Tourette syndrome.

  1982cited by this paper
• The Leyton Obsessional Inventory

  1970cited by this paper

• Sex Differences in Histamine Regulation of Striatal Dopamine

  2025cites this paper
• Sexual dimorphism in histamine regulation of striatal dopamine

  2024influential citation
• Association between body mass index and tic disorders in school-age children

  2024cites this paper
• Discovery of the material basis of Jiuwei Xifeng granules using pharmaco-chemistry and pharmacokinetics.

  2023cites this paper
• Children’s ADHD and Dysregulation Problems, DAT1 Genotype and Methylation, and their Interplay with Family Environment

  2022cites this paper
• Understanding the Pathophysiology of Tourette’s Syndrome: A Review

  2021cites this paper
• The Pathophysiology of Tics; An Evolving Story

  2020cites this paper
• Tics and Tourette Syndrome.

  2019cites this paper
• Transcranial Magnetic Stimulation in Tourette Syndrome: A Historical Perspective, Its Current Use and the Influence of Comorbidities in Treatment Response

  2018cites this paper
• Dopaminergic involvement in a drummer with focal dystonia: A case study.

  2018cites this paper
• Dopaminergic Disturbances in Tourette Syndrome: An Integrative Account.

  2018cites this paper
• Tourette syndrome.

  2017cites this paper
• Gilles de la Tourette syndrome is associated with hypermethylation of the dopamine D2 receptor gene.

  2017cites this paper
• Identification phénoménologique des substrats neurobiologiques de la relation impulsivité / compulsivité : approche transnosographique

  2017cites this paper
• Chapter 7 – Tics and Tourette Syndrome

  2016cites this paper
• Rats overexpressing the dopamine transporter display behavioral and neurobiological abnormalities with relevance to repetitive disorders

  2016cites this paper
• Deep Brain Stimulation for Tourette’s Syndrome: The Case for Targeting the Thalamic Centromedian–Parafascicular Complex

  2016cites this paper
• Striatal magnetic resonance spectroscopy abnormalities in young adult SAPAP3 knockout mice.

  2016cites this paper
• A Review and Update on Tourette Syndrome: Where Is the Field Headed?

  2016cites this paper
• Multidisziplinäre Untersuchung dopaminerger Mechanismen der repetitiven Störungen anhand von zwei Rattenmodellen dopaminerger Dysregulation

  2015cites this paper
• A personal 35 year perspective on Gilles de la Tourette syndrome: assessment, investigations, and management.

  2015cites this paper
• PET and SPECT Imaging in Hyperkinetic Movement Disorders

  2014cites this paper
• Human Brain Imaging of Dopamine Transporters

  2014cites this paper
• Response Inhibition and Interference Control in Obsessive–Compulsive Spectrum Disorders

  2014cites this paper
• Paliperidone extended release for the treatment of pediatric and adolescent patients with Tourette's disorder

  2014cites this paper
• Neuromodulation in Tourette syndrome: dopamine and beyond.

  2013cites this paper
• Motor control, habits, complex motor stereotypies, and Tourette syndrome

  2013cites this paper
• Emerging treatment strategies in Tourette syndrome: what's in the pipeline?

  2013cites this paper
• Functional imaging of dopaminergic neurotransmission in Tourette syndrome.

  2013cites this paper
• Levodopa-stimulated dopamine release in Tourette syndrome

  2013cites this paper
• Pharmacological treatment of tic disorders and Tourette Syndrome.

  2013cites this paper
• Tourette Syndrome and the Spectrum of Neurodevelopmental Tic Disorders

  2012cites this paper
• Tics and Tourette's Syndrome

  2012cites this paper
• Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings

  2012cites this paper
• Pathophysiology of Hyperkinetic Movement Disorders

  2012cites this paper
• Neurobiology of Tourette Syndrome: Current Status and Need for Further Investigation

  2011cites this paper
• European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment

  2011cites this paper
• The neurobiology of repetitive behavior: …and men.

  2011cites this paper
• Tourette syndrome and other tic disorders.

  2011cites this paper
• European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment Veit RoessnerKerstin J. PlessenAribert RothenbergerAndrea G. Ludolph • Renata RizzoLiselotte SkovGerd StrandJeremy S. SternCristiano Termine • Pieter J. Hoekstrathe ESSTS Guidelines Group

  2011cites this paper
• Tics and Gilles de la Tourette Syndrome

  2010cites this paper
• Neurobiological Substrates of Tourette's Disorder

  2010cites this paper
• Role of genetic and environmental factors in tic disorders

  2010cites this paper
• 6 - Tics and Tourette Syndrome

  2010cites this paper
• The analysis of selected neurotransmitter concentrations in serum of patients with Tourette syndrome.

  2010cites this paper
• Tourette syndrome in children: an updated review.

  2010cites this paper
• Evaluation of Tourette’s syndrome by 99mTc-TRODAT-1 SPECT/CT imaging

  2010cites this paper
• Intractable Chronic Motor Tics Dramatically Respond to Clerodendrum inerme (L) Gaertn

  2009cites this paper
• Striatal [11C]dihydrotetrabenazine and [11C]methylphenidate binding in Tourette syndrome

  2009cites this paper
• In vivo imaging of synaptic function in the central nervous system: II. Mental and affective disorders.

  2009cites this paper
• MONOAMIN RENDSZEREK ÉRINTETTSÉGE GYERMEKKORI NEUROPSZICHIÁTRIAI

  2009cites this paper
• Monoamin rendszerek érintettsége gyermekkori neuropszichiátriai zavarokban

  2009cites this paper
• The management of tics

  2009cites this paper
• Functional neuroimaging in Tourette syndrome.

  2009cites this paper
• Pass the torch, please!

  2008cites this paper
• Neurobiological Background of Tic Disorders

  2008cites this paper
• Pediatric Psychopharmacology: Psychopharmacology of Tic Disorders

  2008cites this paper
• The emergence of echolalia while taking sertraline in a patient with Tourette's syndrome.

  2008cites this paper
• [99mTc]TRODAT-1/[123I]IBZM SPECT studies of the dopaminergic system in Tourette syndrome.

  2008cites this paper
• Letters to the Editor

  2008cites this paper
• Neurosurgical strategies for Gilles de la Tourette’s syndrome

  2008cites this paper
• Psychopharmacology of tic disorders.

  2008cites this paper
• Frontal dopaminergic abnormality in Tourette syndrome: a postmortem analysis.

  2007cites this paper
• Dopaminergic candidate genes in Tourette syndrome: Association between tic severity and 3′ UTR polymorphism of the dopamine transporter gene

  2007cites this paper
• Tourette syndrome and tic disorders: a decade of progress.

  2007cites this paper
• 56 – Circuits to Synapses: The Pathophysiology of Tourette Syndrome

  2007cites this paper
• Dopaminergic polymorphisms in Tourette syndrome: Association with the DAT gene (SLC6A3)

  2007influential citation
• Phasic dysfunction of dopamine transmission in Tourette's syndrome evaluated with 99mTc TRODAT-1 imaging.

  2007cites this paper
• Recent advances in Tourette syndrome research.

  2006cites this paper
• Evaluating dopamine transporter activity with 99mTc-TRODAT-1 SPECT in drug-naive Tourette's adults

  2006cites this paper
• Neuroimaging of Tourette Syndrome

  2006cites this paper
• Obsessive-compulsive spectrum disorders: a multidimensional approach.

  2006cites this paper
• Neurodevelopmental and Neuropsychiatric Disorders

  2006cites this paper
• Tic Disorders: Neural Circuits, Neurochemistry, and Neuroimmunology

  2006cites this paper
• Molecular imaging (SPECT and PET) in the evaluation of patients with movement disorders.

  2006cites this paper
• Gilles de la Tourette’s syndrome and its impact in the UK

  2005cites this paper
• Tourette's syndrome: from behaviour to biology.

  2005cites this paper